Bronchial asthma
Conditions
Interventions
None listed
Sponsors
Department of Respiratory Medicine, Fujita Health University of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with bronchial asthma Bronchial asthma patients who underwent the first methacholine airway hyperresponsiveness test
Exclusion criteria
Exclusion criteria: Patients with apparent infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gradual change of methacholinPC-20(provocative concentration that results in a 20% fall in FEV1) in first methacholine hyperresponsiveness test | — |
Secondary
| Measure | Time frame |
|---|---|
| asthma medications, bronchial asthma severity before methacholine hyperresponsiveness test | — |
Countries
Japan
Contacts
Public ContactIsogai Sumito
Fujita Health University of Medicine Department of Respiratory Medicine
Outcome results
None listed